Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 3
1991 3
1992 2
1993 2
1995 3
1996 1
1997 1
1998 3
1999 2
2000 4
2001 6
2002 5
2003 7
2004 4
2005 3
2006 8
2007 7
2008 7
2009 5
2010 11
2011 17
2012 9
2013 9
2014 7
2015 12
2016 8
2017 9
2018 19
2019 8
2020 4
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Results by year
Filters applied: . Clear all
Page 1
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.
Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S; Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan. Sakamoto S, et al. Among authors: inase n. Eur Respir J. 2021 Jan 5;57(1):2000348. doi: 10.1183/13993003.00348-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703779 Clinical Trial.
Executive Summary: Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report.
Fernández Pérez ER, Travis WD, Lynch DA, Brown KK, Johannson KA, Selman M, Ryu JH, Wells AU, Tony Huang YC, Pereira CAC, Scholand MB, Villar A, Inase N, Evans RB, Mette SA, Frazer-Green L. Fernández Pérez ER, et al. Among authors: inase n. Chest. 2021 Aug;160(2):595-615. doi: 10.1016/j.chest.2021.03.067. Epub 2021 Apr 15. Chest. 2021. PMID: 33865835
[Bacterial pneumonia].
Miyake S, Sawabe E, Inase N, Yoshizawa Y. Miyake S, et al. Among authors: inase n. Nihon Rinsho. 2002 Jan;60 Suppl 1:7-16. Nihon Rinsho. 2002. PMID: 11838187 Review. Japanese. No abstract available.
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T. Enomoto N, et al. Among authors: inase n. Thorax. 2022 Feb;77(2):143-153. doi: 10.1136/thoraxjnl-2020-216263. Epub 2021 Jul 16. Thorax. 2022. PMID: 34272335
Treatment and monitoring of hypersensitivity pneumonitis.
Miyazaki Y, Tsutsui T, Inase N. Miyazaki Y, et al. Among authors: inase n. Expert Rev Clin Immunol. 2016 Sep;12(9):953-62. doi: 10.1080/1744666X.2016.1182426. Epub 2016 May 17. Expert Rev Clin Immunol. 2016. PMID: 27117830 Review.
Pathology of hypersensitivity pneumonitis.
Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Takemura T, et al. Among authors: inase n. Curr Opin Pulm Med. 2008 Sep;14(5):440-54. doi: 10.1097/MCP.0b013e3283043dfa. Curr Opin Pulm Med. 2008. PMID: 18664975 Review.
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K, Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H, Taniguchi H, Nakayama T, Nishioka Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society. Homma S, et al. Among authors: inase n. Respir Investig. 2018 Jul;56(4):268-291. doi: 10.1016/j.resinv.2018.03.003. Epub 2018 Jul 3. Respir Investig. 2018. PMID: 29980444 Review.
185 results